prikaz prve stranice dokumenta Primjena odabranih blokatora beta-adrenoreceptora u terapiji kroničnog zatajenja srca
  Download
PDF 602.66 KB
Professional paper - Professional paper
Primjena odabranih blokatora beta-adrenoreceptora u terapiji kroničnog zatajenja srca
Farmaceutski glasnik, 75 (2019), 5; 357-369. urn:nbn:hr:163:877535
Vučić, Marin; Bach-Rojecky, Lidija; Ortner Hadžiabdić, Maja

Institutional repository: Repository of Faculty of Pharmacy and Biochemistry University of Zagreb

Cite this document

Vučić, M., Bach Rojecky, L. & Ortner Hadžiabdić, M. (2019). Primjena odabranih blokatora beta-adrenoreceptora u terapiji kroničnog zatajenja srca. Farmaceutski glasnik, 75. (5), 357-369. Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:877535

Vučić, Marin, et al. "Primjena odabranih blokatora beta-adrenoreceptora u terapiji kroničnog zatajenja srca." Farmaceutski glasnik, vol. 75, no. 5, 2019, pp. 357-369. https://urn.nsk.hr/urn:nbn:hr:163:877535

Vučić, Marin, Lidija Bach Rojecky and Maja Ortner Hadžiabdić. "Primjena odabranih blokatora beta-adrenoreceptora u terapiji kroničnog zatajenja srca." Farmaceutski glasnik 75, no. 5 (2019): 357-369. https://urn.nsk.hr/urn:nbn:hr:163:877535

Vučić, M., Bach Rojecky, L. and Ortner Hadžiabdić, M. (2019) 'Primjena odabranih blokatora beta-adrenoreceptora u terapiji kroničnog zatajenja srca', Farmaceutski glasnik, 75(5), pp. 357-369. Available at: https://urn.nsk.hr/urn:nbn:hr:163:877535 (Accessed 22 November 2024)

Vučić M, Bach Rojecky L, Ortner Hadžiabdić M. Primjena odabranih blokatora beta-adrenoreceptora u terapiji kroničnog zatajenja srca. Farmaceutski glasnik [Internet]. 2019 [cited 2024 November 22];75(5):357-369. Available at: https://urn.nsk.hr/urn:nbn:hr:163:877535

M. Vučić, L. Bach Rojecky and M. Ortner Hadžiabdić, "Primjena odabranih blokatora beta-adrenoreceptora u terapiji kroničnog zatajenja srca", Farmaceutski glasnik, vol. 75, no. 5, pp. 357-369, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:163:877535. [Accessed: 22 November 2024]

Metadata
Title (croatian)Primjena odabranih blokatora beta-adrenoreceptora u terapiji kroničnog zatajenja srca
AuthorMarin Vučić
AuthorLidija Bach-Rojecky
AuthorMaja Ortner Hadžiabdić
Author's institutionUniversity of Zagreb
Faculty of Pharmacy and Biochemistry
(Centre for applied pharmacy)
Author's institutionUniversity of Zagreb
Faculty of Pharmacy and Biochemistry
(Department of pharmacology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Pharmacy
Pharmacy
Abstract (english)
Heart failure is a clinical syndrome characterized by typical signs and symptoms ( e.g. breathlessness, ankle swelling, fatigue, elevated jungular venous pressure) caused by a structural and/or functional cardiac abnormality. 1he goals of treatment in patients with HF are to improve their clinical status, functional capacity and quality of life, prevent hospital admission and reduce mortality. Neurohormonal antagonists (ACE inhibitors, mineralcorticoid receptor antagonists and beta-blockers) have been shown to improve survival in patients with heart failure with reduced ejection fraction and are recommended for the treatment of every patient, unless contraindicated or not tolerated. Therefore, beta-blockers, although primarily developed and used as antihypertensive and antianginal drugs, became important therapy in heart failure management. The evidence of clinical benefit on beta-blockers in patients with chronic heart failure was demonstrated in a number of small studies and in several, large, prospective, randomised, placebo-controlled trials and highlighted four beta-blockers: nebivolol, carvedilol, bisoprolol and metoprolol. This work reviews the pharmacologic characteristics of beta-blockers and their role in heart failure as well as clinical evidence on their effectiveness in patients with heart failure.
Keywords (croatian)
Languagecroatian
Publication typeProfessional paper - Professional paper
Publication statusPublished
Peer reviewPeer review - domestic
Publication versionPublished version
Journal titleFarmaceutski glasnik
Numberingvol. 75, no. 5, pp. 357-369
p-ISSN0014-8202
URN:NBNurn:nbn:hr:163:877535
Publication2019
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2020-06-08 08:47:32